Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia

Abstract

We evaluated cells from 24 patients with B cell chronic lymphocytic leukemia (B-CLL) to determine apoptosis induced by CD5 hypercross-linking. Following the CD5 hypercross-linking with anti-CD5 monoclonal antibodies (MoAbs), we identified 10 patients where CD5 hypercross-linking induced apoptosis (group A) and 14 patients whose cells were resistant to the anti-CD5 MoAbs (group B). The programmed cell death pathway of the cells from patient group A was caspase-3 and poly (ADP-ribose) polymerase (PARP)-dependent, involved a reduction of the mitochondrial transmembrane potential ΔΨ and a down-regulation of the anti-apoptotic Bcl-2, Mcl-1 and iNOS proteins. Early activation-associated molecules such as CD25 and CD69 were expressed at higher levels than in controls after 6 h of culture with anti-CD5 MoAb. The expression of CD5 and of CD72, the ligand for CD5, were significantly lower in group A compared with group B. Anti-CD20 MoAb had similar activity with anti-CD5 MoAb and the combination of the two MoAbs seemed to be additive. In this study, it is suggested that the cells from some B-CLL patients can be induced into programmed cell death by CD5 hypercross-linking with anti-CD5 MoAbs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Reed JC . Molecular biology of chronic lymphocytic leukemia Semin Oncol 1998 25: 11–18

    CAS  PubMed  Google Scholar 

  2. Gottardi D, Alfarano A, De Leo M, Stacchini A, Aragno M, Rigo A, Veneri D, Zanotti R, Pizzolo G, Caligaris-Cappio F . In leukaemic CD5+ B cells the expression of Bcl-2 gene family is shifted toward protection from apoptosis Br J Haematol 1996 94: 612–618

    Article  CAS  Google Scholar 

  3. Klein A, Miera O, Bauer O, Golfier S, Schriever F . Chemosensitivity of B cell chronic lymphocytic leukemia and correlated expression of proteins regulating apoptosis, cell cycle and DNA repair Leukemia 2000 14: 40–46

    Article  CAS  Google Scholar 

  4. Tangye SG, Raison RL . Human cytokines supress apoptosis of leukaemic CD5+ cells and preserve expression of bcl-2 Immunol Cell Biol 1997 75: 127–135

    Article  CAS  Google Scholar 

  5. Molica S, Vitelli G, Levato D, Levato L, Datillo A, Gandolfo GM . Clinico–biological implications of increased serum levels of interleukin-8 in B-cell chronic lymphocytic leukemia Haematology 1999 84: 208–211

    CAS  Google Scholar 

  6. Plate JM, Long BW, Kelkar SB . Role of beta2 integrins in the prevention of apoptosis induction in chronic lymphocytic leukemia B cells Leukemia 2000 14: 34–39

    Article  CAS  Google Scholar 

  7. Mainou-Fowler T, Prentice AG . Modulation of apoptosis with cytokines in B-cell chronic lymphocytic leukemia Leuk Lymphoma 1996 21: 369–377

    Article  CAS  Google Scholar 

  8. Laytragoon-Lewin N, Duhony E, Bai XF, Mellstedt H . Downregulation of the CD95 receptor and defect CD40-mediated signal transduction in B-chronic lymphocytic leukemia cells Eur J Haematol 1998 61: 266–271

    Article  CAS  Google Scholar 

  9. Kneitz C, Goller M, Wilhelm M, Mehringer C, Wohlleben G, Schimpl A, Tony HP . Inhibition of T cell/B cell interaction by B-CLL cells Leukemia 1999 13: 98–104

    Article  CAS  Google Scholar 

  10. Multani PS, Grossbard ML . Monoclonal antibody-based therapies for hematologic malignancies J Clin Oncol 1998 16: 3691–3710

    Article  CAS  Google Scholar 

  11. Meeker TC, Lowder J, Maloney DG, Miller R, Thielelmans K, Warnke R, Levy R . A clinical trial of anti-idiotype therapy for B cell malignancy Blood 1985 73: 1349–1363

    Google Scholar 

  12. McLaughlin P, White CA, Grillo-Lopez AJ . Clinical status and optimal use of Rituximab for B-cell lymphomas Oncology 1998 12: 1769–1777

    Google Scholar 

  13. Nguyen DT, Amess JA, Doughty H, Hendry L, Diamond LW . IDEC-C2B8 anti-CD20 (rituximab) immunotherapy in patients with low-grade non-Hodgkin's lymphoma and lymphoproliferative disorders: evaluation of response on 48 patients Eur J Haematol 1999 62: 76–82

    Article  CAS  Google Scholar 

  14. Osterborg A, Fassas AS, Anagnostopoulos A, Dyer MS, Catovsky D, Mellstedt H . Humanized CD52 monoclonal antibody Campath-1H as first-line treatment in chronic lymphocytic leukemia Br J Haematol 1996 93: 151–153

    Article  CAS  Google Scholar 

  15. Boumsell L, Bernard A, Lepage V, Degos L, Lemerle J, Dausset J . Some chronic lymphocytic leukemia cell bearing surface immunoglobulins share determinants with T cells Eur J Immunol 1978 8: 900–904

    Article  CAS  Google Scholar 

  16. Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G . Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia J Exp Med 1982 155: 623–628

    Article  CAS  Google Scholar 

  17. Kantor AB, Herzenberg LA . Origin of murine B cell lineages Annu Rev Immunol 1993 11: 501–539

    Article  CAS  Google Scholar 

  18. Pers J-O, Jamin C, Le Corre R, Lydyard PM, Youinou P . Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis Eur J Immunol 1998 28: 4170–4176

    Article  CAS  Google Scholar 

  19. Rai KR, Sawitsky A, Cronkite EP, Chanana AD, Levy RN, Pasternak BS . Clinical staging of chronic lymphocytic leukemia Blood 1975 46: 219–234

    CAS  PubMed  Google Scholar 

  20. Chaouchi N, Vazquez A, Galanaud P, Leprince C . B cell antigen receptor-mediated apoptosis. Importance of accessory molecules CD19 and CD22, and of surface IgM cross-linking J Immunol 1995 54: 3096–3104

    Google Scholar 

  21. Shan D, Ledbetter JA, Press OW . Apoptosis of malignant B cells by ligation of CD20 with monoclonal antibodies Blood 1998 91: 1644–1652

    CAS  PubMed  Google Scholar 

  22. Zamzami N, Marchetti P, Castedo M, Zanin C, Vayssiere JC, Petit PX, Kroemer G . Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo J Exp Med 1995 181: 1661–1672

    Article  CAS  Google Scholar 

  23. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE, Poirier GG . Specific proteolytic cleavage of poly (ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res 1993 53: 3976–3985

    CAS  PubMed  Google Scholar 

  24. Yang E, Korsmeyer SJ . Molecular thanatopsis: a discourse on the BCL2 family and cell death Blood 1996 88: 386–401

    CAS  Google Scholar 

  25. Zhao H, Dugas N, Mathiot C, Delmer A, Dugas B, Sigaux F, Kolb J-P . B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity Blood 1998 92: 1031–1043

    CAS  PubMed  Google Scholar 

  26. Kolb JP . Mechanisms involved in the pro- and anti-apoptotic role of NO in human leukemia Leukemia 2000 14: 1685–1694

    Article  CAS  Google Scholar 

  27. Roman V, Zhao H, Fourneau JM, Marconi A, Dugas N, Dugas B, Sigaux F, Kolb JP . Expression of a functional inducible nitric oxide synthase in hairy cell leukaemia and ESKOL cell line Leukemia 2000 14: 696–705

    Article  CAS  Google Scholar 

  28. Cantor GH, Pritchard SM, Dequiedt F, Willems L, Kettmann R, Davis WC . CD5 is dissociated from the B-cell receptor in B cells from bovine leukemia virus-infected, persistently lymphocytotic cattle: consequences to B-cell receptor-mediated apoptosis J Virol 2001 75: 1689–1696

    Article  CAS  Google Scholar 

  29. Verwilghen J, Vandesande R, Vandenberghe P, Ceuppens JL . Crosslinking of the CD5 antigen on human T cells induces functional IL2 receptors Cell Immunol 1990 131: 109–119

    Article  CAS  Google Scholar 

  30. Vandenberghe P, Verwilghen J, Van Vaeck F, Ceuppens JL . Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism Immunology 1993 78: 210–217

    CAS  PubMed  PubMed Central  Google Scholar 

  31. Cerutti A, Trentin L, Zambello R, Sancetta R, Milani A, Tassinari C, Adami F, Agostini C, Semenzato G . The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity J Immunol 1996 157: 1854–1862

    CAS  PubMed  Google Scholar 

  32. Ashwell JD, Longo DL, Bridges SH . T-cell tumor elimination as a result of T-cell receptor-mediated activation Science 1987 237: 61–64

    Article  CAS  Google Scholar 

  33. Ucker DS, Meyers J, Obermiller PS . Activation-driven T cell death. II. Quantitative differences alone distinguish stimuli triggering nontransformed T cell proliferation or death J Immunol 1992 149: 1583–1592

    CAS  PubMed  Google Scholar 

  34. Radvanyi LG, Mills GB, Miller RG . Religation of the T cell receptor after primary activation of mature T cells inhibits proliferation and induces apoptotic cell death J Immunol 1993 150: 5704–5715

    CAS  PubMed  Google Scholar 

  35. Daniel PT, Oettinger U, Mapara MY, Bommert K, Bargou R, Dorken B . Activation and activation-induced death of human tonsillar B cells and Burkitt lymphoma cells: lack of CD95 (Fas/APO-1) ligand expression and function Eur J Immunol 1997 27: 1029–1034

    Article  CAS  Google Scholar 

  36. Parry SL, Hasbold J, Holman M, Klaus GGB . Hypercrosslinking surface IgM or IgD receptors on mature B cells induces apoptosis that is reversed by costimulation with IL-4 and anti-CD40 J Immunol 1994 152: 2821–2829

    CAS  PubMed  Google Scholar 

  37. Gibson J, Neville S, Joshua D, Kronenberg H . CD23 expression in CLL Br J Haematol 1989 72: 598

    Article  CAS  Google Scholar 

  38. Barnett D, Reilly JT . Lack of corelation between cell surface activation antigen expression and clinical stage in CLL Br J Haematol 1989 73: 572

    Article  CAS  Google Scholar 

  39. Peng B, Raveche E . Apoptosis induction in CD5+ (Ly1+) malignant B cells Leukemia 1993 7: 789–794

    CAS  PubMed  Google Scholar 

  40. Van de Velde H, von Koegen I, Luo W, Parnes JR, Thielemans K . The B-cell surface protein CD72/Lyb-2 is the ligand for CD5 Nature 1991 351: 662–665

    Article  CAS  Google Scholar 

  41. Jamin C, Le Corre R, Pers JO, Dueymes M, Lydyard PM, Youinou P . Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ cells Int Immunol 1997 9: 1001–1009

    Article  CAS  Google Scholar 

  42. Jamin C, Lamour A, Pennec L, Hirn M, Le Goff P, Youinou P . Expression of CD5 and CD72 on T and B cell subsets in rheumatoid arthritis and Sjogren's syndrome Clin Exp Immunol 1993 92: 245–250

    Article  CAS  Google Scholar 

  43. Katira A, Kamal M, Gordon J . Occupancy of CD72 (the CD5 counterstructure) enhances interleukin-4-dependent CD23 expression in resting B lymphocytes Immunology 1992 76: 422–426

    CAS  PubMed  PubMed Central  Google Scholar 

  44. Pospisil R, Fitts MG, Mage RG . CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences J Exp Med 1996 184: 1279–1284

    Article  CAS  Google Scholar 

  45. Lankester AC, van Schijndel GM, Cordell JL, van Noesel CJ, van Lier RA . CD5 is associated with the human B cell antigen receptor complex Eur J Immunol 1994 24: 812–816

    Article  CAS  Google Scholar 

  46. Sen G, Bikah G, Venkataraman C, Bondada S . Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells Eur J Immunol 1999 29: 3319–3328

    Article  CAS  Google Scholar 

  47. Pospisil R, Mage RG . CD5 and other superantigens as ‘ticklers’ of the B-cell receptor Immunol Today 1998 19: 106–108

    CAS  PubMed  Google Scholar 

  48. Chen W, Wang HG, Srinivasula S, Alnemri ES, Cooper ND . B cell apoptosis triggered by antigen receptor ligation proceeds via a novel caspase-dependent pathway J Immunol 1999 163: 2483–2491

    CAS  PubMed  Google Scholar 

  49. Berard M, Mondiere P, Casamayor-Palleja M, Hennino A, Bella C, Defrance T . Mitochondria connects the antigen receptor to effector caspases during B cell receptor-induced apoptosis in normal human B cells J Immunol 1999 163: 4655–4662

    CAS  PubMed  Google Scholar 

  50. Nomura T, Han H, Howard MC, Yagita H, Yakura H, Honjo T, Tsubata T . Antigen receptor-mediated B cell death is blocked by signaling via CD72 or treatment with dextran sulfate and is defective in autoimmunity-prone mice Int Immunol 1996 8: 867–875

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Professor Kendo Kiyosawa for valuable advice and Dr Fumihiro Ishida for constructive discussion. We also thank Mr Susumu Ito for technical assistance and Drs Mayumi Ueno, Shigetaka Shimodaira, Shojiro Takagi, Naohiko Chiba, Hiroshi Morishita, Shigeki Seki, Naoaki Ichikawa, Toshiro Ito, Hikaru Kobayashi and Hiroshi Saito for providing patient samples.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cioca, D., Kitano, K. Apoptosis induction by hypercross-linking of the surface antigen CD5 with anti-CD5 monoclonal antibodies in B cell chronic lymphocytic leukemia. Leukemia 16, 335–343 (2002). https://doi.org/10.1038/sj.leu.2402393

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.leu.2402393

Keywords

This article is cited by

Search

Quick links